Curis (CRIS) Share-based Compensation Growth (3y) (2013 - 2026)
Curis (CRIS) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
4.80% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Curis |
8.37 Mn |
-6.63 Mn |
- |
-25.58% |
| Date | Value |
|---|
| Mar 31, 2026 |
-25.58% |
| Dec 31, 2025 |
-23.04% |
| Sep 30, 2025 |
-11.30% |
| Jun 30, 2025 |
-16.73% |
| Mar 31, 2025 |
-12.17% |
| Dec 31, 2024 |
-3.87% |
| Sep 30, 2024 |
-1.86% |
| Jun 30, 2024 |
10.15% |
| Mar 31, 2024 |
12.36% |
| Dec 31, 2023 |
21.41% |
| Sep 30, 2023 |
37.88% |
| Jun 30, 2023 |
34.52% |
| Mar 31, 2023 |
30.69% |
| Dec 31, 2022 |
36.09% |
| Sep 30, 2022 |
24.63% |
| Jun 30, 2022 |
46.06% |
| Mar 31, 2022 |
38.19% |
| Dec 31, 2021 |
31.69% |
| Sep 30, 2021 |
17.87% |
| Jun 30, 2021 |
2.36% |
